Echo Therapeutics, Inc. develops non-invasive, wireless, and continuous glucose monitoring system. It develops needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals. The company was founded on September 14, 2007 and is headquartered in Iselin, NJ.
